The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
Open accessAbstract
BACKGROUND: It is unknown whether eradication of Helicobacter pylori infection prevents development of gastric adenocarcinoma. To determine whether screening and treatment trials are warranted, we conducted a cost-effectiveness analysis to estimate the costs and benefits associated with screening for H pylori at age 50 and treating those individuals infected with antibiotics. METHODS: We compared two interventions: (1) screen for H pylori and treat those with a positive test, and (2) do not screen and do not treat. Estimates of risks and costs were obtained by review of published reports. Since the efficacy of H pylori therapy in cancer prevention is unknown, we did sensitivity analyses, varying this estimate widely. In our base-case analysis, we assumed that H pylori treatment prevented 30% of attributable gastric cancers. FINDINGS: In the base-case analysis, 11,646,000 persons in the US would be screened and 4,658,400 treated, at a cost of $996 million. Cost-effectiveness was $25,000 per year of life saved. Cost-effectiveness was sensitive to the efficacy of the cancer prevention strategy. At low efficacy rates (< 10%), the screening programme was more expensive (> $75,000 per year of life saved). In a high-risk group such as Japanese-Americans, however, screening and treatment required less than $50,000 per year of life saved, even at 5% treatment efficacy. INTERPRETATION: Screening and treatment for H pylori infection is potentially cost-effective in the prevention of gastric cancer, particularly in high-risk populations. Cancer prevention trials are strongly recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
Self-citationMarkov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Statistical Abstract of the United States: 2007
(2007) · Choice Reviews Online · doi:10.5860/choice.45-1769 · Cited by 2,398
Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., & Sitas, F. (1991) · BMJ · doi:10.1136/bmj.302.6788.1302 · Cited by 1,380
Helicobacter pylori in peptic ulcer disease.
van Rensburg, O. (2004) · PubMed · Cited by 1,310
Helicobacter pylori in Peptic Ulcer Disease
Yamada, T. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520010077036 · Cited by 1,024
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States
Graham, D. Y., Malaty, H. M., Evans, D. G., Evans, D. J., Klein, P. D., & Adam, E. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90644-z · Cited by 960
Prevalence of Helicobacter pylori Infection and Histologic Gastritis in Asymptomatic Persons
Dooley, C. P., Cohen, H., Fitzgibbons, P. L., Bauer, M., Appleman, M. D., Perez-Perez, G. I., & Blaser, M. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912073212302 · Cited by 760
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population
Asaka, M., Kimura, T., Kudo, M., Takeda, H., Mitani, S., Miyazaki, T., Miki, K., & Graham, D. Y. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90156-s · Cited by 625
The incidence of Helicobacter pylori infection.
Parsonnet, J. (1995) · PubMed · Cited by 438
Self-citationHELICOBACTER PYLORI AND GASTRIC CANCER
Parsonnet, J. (1993) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00265-x · Cited by 343
Self-citation(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.23.1701 · Cited by 210
Forman, D., Webb, P., & Parsonnet, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91034-0 · Cited by 207
Self-citationHornsveld, H., Garssen, B., Dop, M. F., van Spiegel, P., & de Haes, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02024-7 · Cited by 168
Efficacy and Side Effects of a Triple Drug Regimen for the Eradication of Helicobacter pylori
Thijs, J. C., van Zwet, A. A., & Oey, H. B. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098287 · Cited by 67
Life Expectancy in Four U.S. Racial/Ethnic Populations
Hahn, R. A., & Eberhardt, S. C. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00004 · Cited by 46
Increased Risk of Helicobacter pylori Associated with Birth in Wartime and Post-War Japan
Replogle, M. L., KASUMI, W., Ishikawa, K., et al. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.1.210 · Cited by 39
Some of the Tough Decisions Required by a National Health Plan
Russell, L. B. (1989) · Science · doi:10.1126/science.2510299 · Cited by 37
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
Metadata
- Authors
- Parsonnet, J., Harris, R. A., Hack, H. M., & Owens, D. K.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1996-07
- Volume
- 348
- Issue
- 9021
- Pages
- 150-154
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2163581846
- Cited by
- 333
- References
- 19
- FWCI
- 27.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.